Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -0.20% | 83.10 | 0.9% | $974.49m | |
| KITE | Kite Pharma, Inc. | 0.03% | 179.36 | 16.1% | $742.33m | |
| CELG | Celgene Corporation | 0.46% | 144.55 | 1.1% | $500.01m | |
| AMGN | Amgen Inc. | 0.16% | 186.05 | 1.1% | $483.92m | |
| BIIB | Biogen Inc. | -0.14% | 318.00 | 1.2% | $421.75m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.45% | 439.00 | 2.7% | $359.48m | |
| ALNY | Alnylam Pharmaceuticals, Inc | 1.81% | 115.86 | 10.7% | $250.17m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.46% | 143.48 | 1.9% | $230.03m | |
| JUNO | Juno Therapeutics, Inc. | -4.81% | 42.97 | 14.6% | $225.37m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.38% | 149.17 | 1.9% | $208.45m | |
| INCY | Incyte Corporation | -1.22% | 109.50 | 2.6% | $205.12m | |
| ILMN | Illumina, Inc. | -0.63% | 200.14 | 3.5% | $158.40m | |
| BLUE | Bluebird Bio, Inc. | 1.17% | 130.25 | 19.3% | $143.09m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.79% | 94.20 | 4.4% | $136.30m | |
| CLVS | Clovis Oncology, Inc. | -2.95% | 76.25 | 18.0% | $132.43m |
Company Profile
Applied Genetic Technologies Corp. is a clinical-stage biotechnology company, which engages in the development of gene therapy products designed to transform the lives of patients with severe diseases in ophthalmology. Its product candidates are designed to treat X-linked retinoschisis, Achromatopsia, and X-linked retinitis pigmentosa. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.